

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 5.96924224 |
| 2 | type I interferon signaling pathway (GO:0060337) | 5.31859693 |
| 3 | cellular response to type I interferon (GO:0071357) | 5.31859693 |
| 4 | response to type I interferon (GO:0034340) | 5.28583365 |
| 5 | ribosome assembly (GO:0042255) | 5.18824201 |
| 6 | nucleobase biosynthetic process (GO:0046112) | 5.16334718 |
| 7 | vitamin transmembrane transport (GO:0035461) | 5.11674628 |
| 8 | regulation of spindle organization (GO:0090224) | 5.00468417 |
| 9 | mitotic metaphase plate congression (GO:0007080) | 4.98177076 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97643420 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92412584 |
| 12 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.76210580 |
| 13 | ribosome biogenesis (GO:0042254) | 4.61741596 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.51674253 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.51674253 |
| 16 | regulation of mitotic spindle organization (GO:0060236) | 4.48492381 |
| 17 | regulation of translational termination (GO:0006449) | 4.39211125 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36093008 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.36093008 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36093008 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36093008 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36093008 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 4.36093008 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.34924532 |
| 25 | folic acid metabolic process (GO:0046655) | 4.33517619 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33358145 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 4.19008215 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.14462376 |
| 29 | folic acid transport (GO:0015884) | 4.03477177 |
| 30 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.01469335 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.97200131 |
| 32 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.96988969 |
| 33 | positive regulation of chromosome segregation (GO:0051984) | 3.95570807 |
| 34 | T cell migration (GO:0072678) | 3.94598640 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.93700653 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.91559339 |
| 37 | formation of translation preinitiation complex (GO:0001731) | 3.90176315 |
| 38 | DNA replication checkpoint (GO:0000076) | 3.87260873 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.86750792 |
| 40 | protein localization to kinetochore (GO:0034501) | 3.84635324 |
| 41 | response to interferon-alpha (GO:0035455) | 3.82334970 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.77555479 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.76708469 |
| 44 | cellular response to interferon-alpha (GO:0035457) | 3.70819353 |
| 45 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.68680317 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.68143252 |
| 47 | autophagic vacuole assembly (GO:0000045) | 3.65747882 |
| 48 | detection of other organism (GO:0098543) | 3.65511470 |
| 49 | response to peptidoglycan (GO:0032494) | 3.62389700 |
| 50 | metaphase plate congression (GO:0051310) | 3.60045830 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 3.59401177 |
| 52 | nuclear pore organization (GO:0006999) | 3.58712288 |
| 53 | positive regulation of tolerance induction (GO:0002645) | 3.57372614 |
| 54 | negative regulation of viral genome replication (GO:0045071) | 3.56715918 |
| 55 | mitotic nuclear envelope disassembly (GO:0007077) | 3.56102708 |
| 56 | positive regulation of type 2 immune response (GO:0002830) | 3.55182947 |
| 57 | detection of bacterium (GO:0016045) | 3.54453351 |
| 58 | histone H2A monoubiquitination (GO:0035518) | 3.54068977 |
| 59 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.51362034 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50690440 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.49836946 |
| 62 | nuclear envelope disassembly (GO:0051081) | 3.41912146 |
| 63 | membrane disassembly (GO:0030397) | 3.41912146 |
| 64 | blastocyst development (GO:0001824) | 3.40359074 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.38074739 |
| 66 | intestinal epithelial cell development (GO:0060576) | 3.37643309 |
| 67 | regulation of translation in response to stress (GO:0043555) | 3.35077294 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34194833 |
| 69 | rRNA modification (GO:0000154) | 3.31388463 |
| 70 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.30907221 |
| 71 | GMP metabolic process (GO:0046037) | 3.30808739 |
| 72 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30781907 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29944502 |
| 74 | regulation of type 2 immune response (GO:0002828) | 3.29126668 |
| 75 | response to interferon-beta (GO:0035456) | 3.26729207 |
| 76 | negative regulation of type 2 immune response (GO:0002829) | 3.26176207 |
| 77 | protein localization to chromosome, centromeric region (GO:0071459) | 3.23336855 |
| 78 | defense response to protozoan (GO:0042832) | 3.23299100 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23266079 |
| 80 | nuclear pore complex assembly (GO:0051292) | 3.23226178 |
| 81 | natural killer cell activation involved in immune response (GO:0002323) | 3.22921020 |
| 82 | lung-associated mesenchyme development (GO:0060484) | 3.22748827 |
| 83 | mitotic sister chromatid segregation (GO:0000070) | 3.21793305 |
| 84 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.20806351 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17170428 |
| 86 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.16924796 |
| 87 | cellular response to interferon-gamma (GO:0071346) | 3.16643774 |
| 88 | B cell mediated immunity (GO:0019724) | 3.15672529 |
| 89 | positive regulation of autophagy (GO:0010508) | 3.15519048 |
| 90 | spindle assembly involved in mitosis (GO:0090307) | 3.14729303 |
| 91 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.13776636 |
| 92 | regulation of RNA export from nucleus (GO:0046831) | 3.13400281 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.12555700 |
| 94 | dendritic cell chemotaxis (GO:0002407) | 3.11988876 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11862999 |
| 96 | nuclear envelope organization (GO:0006998) | 3.11763324 |
| 97 | regulation of interleukin-12 production (GO:0032655) | 3.11386695 |
| 98 | positive regulation of interferon-beta production (GO:0032728) | 3.11382186 |
| 99 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10437147 |
| 100 | regulation of G0 to G1 transition (GO:0070316) | 3.10373748 |
| 101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07907800 |
| 102 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.07709415 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07155090 |
| 104 | response to host immune response (GO:0052572) | 3.06810327 |
| 105 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06810327 |
| 106 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06605356 |
| 107 | response to protozoan (GO:0001562) | 3.05601429 |
| 108 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.05305038 |
| 109 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.02886649 |
| 110 | histone H2A ubiquitination (GO:0033522) | 3.02101617 |
| 111 | detection of external biotic stimulus (GO:0098581) | 3.01698521 |
| 112 | interferon-gamma secretion (GO:0072643) | 3.01352536 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.01328667 |
| 114 | termination of RNA polymerase I transcription (GO:0006363) | 3.01016367 |
| 115 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.00843806 |
| 116 | transcription from RNA polymerase I promoter (GO:0006360) | 3.00439454 |
| 117 | * response to interferon-gamma (GO:0034341) | 2.99948327 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.99473034 |
| 119 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.99350390 |
| 120 | termination of RNA polymerase III transcription (GO:0006386) | 2.99350390 |
| 121 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.99295907 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.99174616 |
| 123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98963773 |
| 124 | regulation of chromosome segregation (GO:0051983) | 2.98936065 |
| 125 | defense response to virus (GO:0051607) | 2.98902783 |
| 126 | maturation of SSU-rRNA (GO:0030490) | 2.98664121 |
| 127 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.98557805 |
| 128 | positive regulation of interleukin-17 production (GO:0032740) | 2.98379358 |
| 129 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.98233580 |
| 130 | regulation of chronic inflammatory response (GO:0002676) | 2.98189676 |
| 131 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97980920 |
| 132 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.97797094 |
| 133 | germinal center formation (GO:0002467) | 2.97174845 |
| 134 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97109832 |
| 135 | establishment of chromosome localization (GO:0051303) | 2.97014734 |
| 136 | histone-serine phosphorylation (GO:0035404) | 2.96440064 |
| 137 | microglial cell activation (GO:0001774) | 2.96026281 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95417505 |
| 139 | positive regulation of interleukin-12 production (GO:0032735) | 2.95174585 |
| 140 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.93383246 |
| 141 | myeloid dendritic cell differentiation (GO:0043011) | 2.91702098 |
| 142 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.91461234 |
| 143 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.89953504 |
| 144 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89291046 |
| 145 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.88726652 |
| 146 | negative T cell selection (GO:0043383) | 2.88547286 |
| 147 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.88395989 |
| 148 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.87699468 |
| 149 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86478115 |
| 150 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.85905913 |
| 151 | cellular response to interferon-beta (GO:0035458) | 2.85740343 |
| 152 | NADH metabolic process (GO:0006734) | 2.84571849 |
| 153 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.84264803 |
| 154 | negative regulation of innate immune response (GO:0045824) | 2.83940349 |
| 155 | regulation of RIG-I signaling pathway (GO:0039535) | 2.82872265 |
| 156 | maturation of 5.8S rRNA (GO:0000460) | 2.82214777 |
| 157 | spindle checkpoint (GO:0031577) | 2.82107768 |
| 158 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.82080604 |
| 159 | detection of molecule of bacterial origin (GO:0032490) | 2.81854328 |
| 160 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.79653829 |
| 161 | negative regulation of translational initiation (GO:0045947) | 2.79207980 |
| 162 | labyrinthine layer development (GO:0060711) | 2.77966004 |
| 163 | rRNA processing (GO:0006364) | 2.76841603 |
| 164 | pore complex assembly (GO:0046931) | 2.75557644 |
| 165 | pantothenate metabolic process (GO:0015939) | 2.74662673 |
| 166 | mitotic spindle checkpoint (GO:0071174) | 2.74373370 |
| 167 | 7-methylguanosine mRNA capping (GO:0006370) | 2.72788782 |
| 168 | synaptonemal complex assembly (GO:0007130) | 2.72623493 |
| 169 | rRNA metabolic process (GO:0016072) | 2.72186572 |
| 170 | protein localization to chromosome (GO:0034502) | 2.71939819 |
| 171 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.71878025 |
| 172 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.71878025 |
| 173 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.71878025 |
| 174 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71495835 |
| 175 | mitotic G1/S transition checkpoint (GO:0044819) | 2.69680832 |
| 176 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.69644652 |
| 177 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.69644652 |
| 178 | inner cell mass cell proliferation (GO:0001833) | 2.67762283 |
| 179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64666469 |
| 180 | modified amino acid transport (GO:0072337) | 2.64141473 |
| 181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63740507 |
| 182 | regulation of translational initiation (GO:0006446) | 2.63390272 |
| 183 | negative regulation of macroautophagy (GO:0016242) | 2.62730856 |
| 184 | negative regulation of chromosome segregation (GO:0051985) | 2.61577799 |
| 185 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.61084741 |
| 186 | NLS-bearing protein import into nucleus (GO:0006607) | 2.60525036 |
| 187 | regulation of exit from mitosis (GO:0007096) | 2.60136356 |
| 188 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.59618577 |
| 189 | G1 DNA damage checkpoint (GO:0044783) | 2.58429290 |
| 190 | RNA capping (GO:0036260) | 2.56956003 |
| 191 | 7-methylguanosine RNA capping (GO:0009452) | 2.56956003 |
| 192 | mitotic spindle assembly checkpoint (GO:0007094) | 2.56920583 |
| 193 | IMP biosynthetic process (GO:0006188) | 2.54989062 |
| 194 | trophectodermal cell differentiation (GO:0001829) | 2.53515177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.31480987 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.74010180 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76334029 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.67142258 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.50684328 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.33150930 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16384955 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14093993 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91873120 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89821621 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87232141 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76550958 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.73910451 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73564989 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.69651821 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.62457189 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.59262605 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.56545894 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.50691804 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49965630 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49625104 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.39648106 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.19772317 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14097005 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08959152 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04628712 |
| 27 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.03251727 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02624820 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.02179242 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.00975585 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.00196267 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96861688 |
| 33 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96602489 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96012459 |
| 35 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.95419749 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94472898 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.93780822 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.93249141 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90251621 |
| 40 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86912222 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85628022 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83599220 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.80773089 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80074822 |
| 45 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.78232366 |
| 46 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.77398897 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76188104 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75902176 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74863268 |
| 50 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73649026 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72746425 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71539293 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68517580 |
| 54 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.67094317 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.66327661 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63389839 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61276899 |
| 58 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.60362037 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59761087 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.56715173 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53728523 |
| 62 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.49288878 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47844118 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.47587481 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.47334135 |
| 66 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46856872 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43183558 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.42047053 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41700562 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40557968 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40344775 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39951800 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39001047 |
| 74 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38289579 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38144947 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37724895 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37650779 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37580324 |
| 79 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36369462 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35224518 |
| 81 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32573632 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32375485 |
| 83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29428281 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29233172 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29125644 |
| 86 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29088855 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28729596 |
| 88 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25574474 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25299517 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23963140 |
| 91 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22844818 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22711115 |
| 93 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21696746 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20817394 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20648042 |
| 96 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20349729 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19782582 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18566851 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.18052471 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17624161 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16683960 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16643955 |
| 103 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15088860 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15004148 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14729803 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13996785 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13567371 |
| 108 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13367584 |
| 109 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13302527 |
| 110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12862660 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12229982 |
| 112 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11789464 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09574895 |
| 114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09134064 |
| 115 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08197049 |
| 116 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.08175552 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07996930 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06378719 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06043985 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05514166 |
| 121 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.05198682 |
| 122 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05136576 |
| 123 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04704966 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04343441 |
| 125 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04310655 |
| 126 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03268257 |
| 127 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03121827 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02224378 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01752827 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01498251 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01084456 |
| 132 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01023188 |
| 133 | MYB_26560356_Chip-Seq_TH1_Human | 1.01016132 |
| 134 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00788938 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00700936 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00692316 |
| 137 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00527308 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99769116 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99738209 |
| 140 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98584031 |
| 141 | MAF_26560356_Chip-Seq_TH1_Human | 0.98419356 |
| 142 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97586500 |
| 143 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96536383 |
| 144 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94616604 |
| 145 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94396070 |
| 146 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94121204 |
| 147 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92800754 |
| 148 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92794859 |
| 149 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.92557561 |
| 150 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92443178 |
| 151 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91664276 |
| 152 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91619300 |
| 153 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.90652288 |
| 154 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89821271 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89787518 |
| 156 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89369060 |
| 157 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88834457 |
| 158 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88685304 |
| 159 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88677640 |
| 160 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88181975 |
| 161 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87799107 |
| 162 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.87218841 |
| 163 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87205786 |
| 164 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85905825 |
| 165 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.85855518 |
| 166 | MYB_26560356_Chip-Seq_TH2_Human | 0.85174363 |
| 167 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83295888 |
| 168 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83126954 |
| 169 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82422898 |
| 170 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82345602 |
| 171 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81886873 |
| 172 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81487407 |
| 173 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80450655 |
| 174 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78774843 |
| 175 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78050489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.32622191 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.95493262 |
| 3 | MP0003724_increased_susceptibility_to | 3.81681357 |
| 4 | MP0008260_abnormal_autophagy | 3.67116400 |
| 5 | MP0009840_abnormal_foam_cell | 3.34012855 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.17215697 |
| 7 | MP0003077_abnormal_cell_cycle | 3.07201129 |
| 8 | MP0010307_abnormal_tumor_latency | 2.83021787 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.73423653 |
| 10 | MP0003718_maternal_effect | 2.63310603 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.35683839 |
| 12 | MP0008057_abnormal_DNA_replication | 2.20830577 |
| 13 | MP0001730_embryonic_growth_arrest | 2.19573111 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.15936413 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.01294806 |
| 16 | MP0005076_abnormal_cell_differentiation | 1.96787108 |
| 17 | MP0003123_paternal_imprinting | 1.96392843 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.93593713 |
| 19 | MP0000350_abnormal_cell_proliferation | 1.93134282 |
| 20 | MP0008058_abnormal_DNA_repair | 1.90124006 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.90040006 |
| 22 | MP0008007_abnormal_cellular_replicative | 1.89356891 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.87429342 |
| 24 | MP0003786_premature_aging | 1.81970657 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.81192650 |
| 26 | MP0005310_abnormal_salivary_gland | 1.78385585 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.77550031 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.77550031 |
| 29 | MP0003303_peritoneal_inflammation | 1.76772852 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.75082871 |
| 31 | MP0008469_abnormal_protein_level | 1.73141101 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.65983621 |
| 33 | MP0005380_embryogenesis_phenotype | 1.64850661 |
| 34 | MP0001672_abnormal_embryogenesis/_devel | 1.64850661 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.64259596 |
| 36 | MP0009764_decreased_sensitivity_to | 1.64246115 |
| 37 | MP0005671_abnormal_response_to | 1.54097129 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.52418746 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49991278 |
| 40 | MP0003984_embryonic_growth_retardation | 1.49675750 |
| 41 | MP0001873_stomach_inflammation | 1.48649668 |
| 42 | MP0004947_skin_inflammation | 1.47462904 |
| 43 | MP0002088_abnormal_embryonic_growth/wei | 1.47032428 |
| 44 | MP0006082_CNS_inflammation | 1.42836793 |
| 45 | MP0000685_abnormal_immune_system | 1.41884712 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.41189628 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.41108331 |
| 48 | MP0005621_abnormal_cell_physiology | 1.37963977 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.37556555 |
| 50 | MP0002080_prenatal_lethality | 1.37402179 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.35312637 |
| 52 | MP0003448_altered_tumor_morphology | 1.33245700 |
| 53 | MP0001697_abnormal_embryo_size | 1.31255853 |
| 54 | MP0001800_abnormal_humoral_immune | 1.28568729 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.28003098 |
| 56 | MP0002398_abnormal_bone_marrow | 1.26543227 |
| 57 | MP0005166_decreased_susceptibility_to | 1.25807982 |
| 58 | MP0002723_abnormal_immune_serum | 1.25406969 |
| 59 | MP0003866_abnormal_defecation | 1.24652346 |
| 60 | MP0008932_abnormal_embryonic_tissue | 1.24130067 |
| 61 | MP0009278_abnormal_bone_marrow | 1.23087043 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.22309991 |
| 63 | MP0004510_myositis | 1.22071099 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.20933016 |
| 65 | MP0001851_eye_inflammation | 1.19191686 |
| 66 | MP0002722_abnormal_immune_system | 1.18738451 |
| 67 | MP0000313_abnormal_cell_death | 1.18303777 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.18097880 |
| 69 | MP0003075_altered_response_to | 1.18016926 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.17629573 |
| 71 | MP0003436_decreased_susceptibility_to | 1.17563219 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.15940832 |
| 73 | MP0000343_altered_response_to | 1.15822075 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.15719477 |
| 75 | MP0005384_cellular_phenotype | 1.15429584 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.14950563 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.14604544 |
| 78 | MP0001819_abnormal_immune_cell | 1.14272967 |
| 79 | MP0003878_abnormal_ear_physiology | 1.14267926 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 1.14267926 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.14052416 |
| 82 | MP0005164_abnormal_response_to | 1.13956443 |
| 83 | MP0000716_abnormal_immune_system | 1.11934467 |
| 84 | MP0002420_abnormal_adaptive_immunity | 1.11494070 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.11230751 |
| 86 | MP0001661_extended_life_span | 1.08006623 |
| 87 | MP0000358_abnormal_cell_content/ | 1.07389427 |
| 88 | MP0000750_abnormal_muscle_regeneration | 1.06261582 |
| 89 | MP0005451_abnormal_body_composition | 1.05144783 |
| 90 | MP0009763_increased_sensitivity_to | 1.04393338 |
| 91 | MP0001790_abnormal_immune_system | 1.03320186 |
| 92 | MP0005387_immune_system_phenotype | 1.03320186 |
| 93 | MP0005395_other_phenotype | 1.02565740 |
| 94 | MP0004883_abnormal_blood_vessel | 1.01131141 |
| 95 | MP0009785_altered_susceptibility_to | 1.00819018 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 1.00229210 |
| 97 | MP0002429_abnormal_blood_cell | 0.99167908 |
| 98 | MP0000604_amyloidosis | 0.98833901 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.97253535 |
| 100 | MP0001756_abnormal_urination | 0.97094805 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.96935893 |
| 102 | MP0005360_urolithiasis | 0.96444573 |
| 103 | MP0001542_abnormal_bone_strength | 0.95754822 |
| 104 | MP0000858_altered_metastatic_potential | 0.95591980 |
| 105 | MP0002419_abnormal_innate_immunity | 0.94588511 |
| 106 | MP0000627_abnormal_mammary_gland | 0.94397170 |
| 107 | MP0002132_abnormal_respiratory_system | 0.94376452 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.93336521 |
| 109 | MP0002084_abnormal_developmental_patter | 0.93038651 |
| 110 | MP0002006_tumorigenesis | 0.92636064 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.92081932 |
| 112 | MP0005025_abnormal_response_to | 0.91505421 |
| 113 | MP0002085_abnormal_embryonic_tissue | 0.89617617 |
| 114 | MP0001849_ear_inflammation | 0.88346926 |
| 115 | MP0008004_abnormal_stomach_pH | 0.87201984 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.86366389 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.85970781 |
| 118 | MP0003329_amyloid_beta_deposits | 0.82867635 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.82470112 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.82135819 |
| 121 | MP0002405_respiratory_system_inflammati | 0.81827023 |
| 122 | MP0003690_abnormal_glial_cell | 0.80975589 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.80602378 |
| 124 | MP0002210_abnormal_sex_determination | 0.80218067 |
| 125 | MP0002148_abnormal_hypersensitivity_rea | 0.79638618 |
| 126 | MP0000609_abnormal_liver_physiology | 0.79588489 |
| 127 | MP0001663_abnormal_digestive_system | 0.77431868 |
| 128 | MP0003045_fibrosis | 0.77361076 |
| 129 | MP0002163_abnormal_gland_morphology | 0.75702829 |
| 130 | MP0001929_abnormal_gametogenesis | 0.75660454 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.75506063 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.75283600 |
| 133 | MP0003828_pulmonary_edema | 0.73474037 |
| 134 | MP0003195_calcinosis | 0.73289514 |
| 135 | MP0000490_abnormal_crypts_of | 0.73096247 |
| 136 | MP0004197_abnormal_fetal_growth/weight/ | 0.73025171 |
| 137 | MP0005365_abnormal_bile_salt | 0.71408336 |
| 138 | MP0002254_reproductive_system_inflammat | 0.71016527 |
| 139 | MP0001853_heart_inflammation | 0.70955156 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.70599088 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.70264274 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.63467394 |
| 143 | MP0004019_abnormal_vitamin_homeostasis | 0.63429638 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.62686207 |
| 145 | MP0003795_abnormal_bone_structure | 0.62553376 |
| 146 | MP0003091_abnormal_cell_migration | 0.61914496 |
| 147 | MP0000249_abnormal_blood_vessel | 0.61277185 |
| 148 | MP0008874_decreased_physiological_sensi | 0.60770801 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60712714 |
| 150 | MP0000465_gastrointestinal_hemorrhage | 0.60657768 |
| 151 | MP0005390_skeleton_phenotype | 0.60482896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 5.15586890 |
| 2 | Orchitis (HP:0100796) | 4.65054157 |
| 3 | Optic neuritis (HP:0100653) | 4.62343656 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.62343656 |
| 5 | Myositis (HP:0100614) | 4.48849764 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 4.08540896 |
| 7 | Impulsivity (HP:0100710) | 4.03626563 |
| 8 | Carpal bone hypoplasia (HP:0001498) | 4.01168660 |
| 9 | Increased IgM level (HP:0003496) | 4.00397730 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.96863721 |
| 11 | Breast hypoplasia (HP:0003187) | 3.95036221 |
| 12 | Pustule (HP:0200039) | 3.87060920 |
| 13 | Vasculitis (HP:0002633) | 3.83927134 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.83777644 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.75567993 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74806889 |
| 17 | Stomatitis (HP:0010280) | 3.72037475 |
| 18 | Entropion (HP:0000621) | 3.66998261 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.66220013 |
| 20 | Hyperglycinemia (HP:0002154) | 3.52944962 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.39756093 |
| 22 | Multiple enchondromatosis (HP:0005701) | 3.39671592 |
| 23 | Recurrent viral infections (HP:0004429) | 3.37089112 |
| 24 | T lymphocytopenia (HP:0005403) | 3.34915502 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.31947613 |
| 26 | Bundle branch block (HP:0011710) | 3.29568392 |
| 27 | Malnutrition (HP:0004395) | 3.28721925 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28282178 |
| 29 | Tetraplegia (HP:0002445) | 3.27799716 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.27702230 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.26066864 |
| 32 | Atrioventricular block (HP:0001678) | 3.23230110 |
| 33 | Abnormality of the anterior horn cell (HP:0006802) | 3.22379583 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 3.22379583 |
| 35 | Encephalitis (HP:0002383) | 3.21109585 |
| 36 | Meningitis (HP:0001287) | 3.17789598 |
| 37 | Ventricular fibrillation (HP:0001663) | 3.15025454 |
| 38 | Hemoptysis (HP:0002105) | 3.14998337 |
| 39 | Colitis (HP:0002583) | 3.12224974 |
| 40 | Recurrent skin infections (HP:0001581) | 3.11629197 |
| 41 | Gout (HP:0001997) | 3.06628031 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.03983926 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.03983926 |
| 44 | Obstructive lung disease (HP:0006536) | 3.02379391 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02379391 |
| 46 | Personality changes (HP:0000751) | 3.01534174 |
| 47 | Keratoconjunctivitis (HP:0001096) | 2.98969138 |
| 48 | Anorexia (HP:0002039) | 2.96548685 |
| 49 | Hyperglycinuria (HP:0003108) | 2.93521551 |
| 50 | Rough bone trabeculation (HP:0100670) | 2.92619179 |
| 51 | Gingivitis (HP:0000230) | 2.91776715 |
| 52 | Spinal muscular atrophy (HP:0007269) | 2.90103939 |
| 53 | Urticaria (HP:0001025) | 2.88561642 |
| 54 | Abnormality of the labia minora (HP:0012880) | 2.80385379 |
| 55 | Mutism (HP:0002300) | 2.79894277 |
| 56 | Abnormality of T cells (HP:0002843) | 2.79547192 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.79186079 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.79018646 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79018646 |
| 60 | Granulocytopenia (HP:0001913) | 2.78336108 |
| 61 | Leukocytosis (HP:0001974) | 2.74151374 |
| 62 | Patellar aplasia (HP:0006443) | 2.73216629 |
| 63 | Dysautonomia (HP:0002459) | 2.73139840 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.72705182 |
| 65 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.72688767 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.71784781 |
| 67 | Chest pain (HP:0100749) | 2.71167214 |
| 68 | Ureteral duplication (HP:0000073) | 2.70161945 |
| 69 | Global brain atrophy (HP:0002283) | 2.68257183 |
| 70 | Fatigue (HP:0012378) | 2.66831860 |
| 71 | Abnormality of the umbilical cord (HP:0010881) | 2.65695452 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64303592 |
| 73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64303592 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64303592 |
| 75 | Eosinophilia (HP:0001880) | 2.64019067 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.62823659 |
| 77 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.62794937 |
| 78 | Hypertensive crisis (HP:0100735) | 2.60038593 |
| 79 | Increased IgE level (HP:0003212) | 2.59319863 |
| 80 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.59273604 |
| 81 | Gangrene (HP:0100758) | 2.59059366 |
| 82 | Arterial thrombosis (HP:0004420) | 2.56296094 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.56012080 |
| 84 | Difficulty climbing stairs (HP:0003551) | 2.55220799 |
| 85 | Abnormal neuron morphology (HP:0012757) | 2.51527567 |
| 86 | Abnormality of the motor neurons (HP:0002450) | 2.51527567 |
| 87 | Increased serum ferritin (HP:0003281) | 2.50331536 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.49493361 |
| 89 | Progressive muscle weakness (HP:0003323) | 2.48336750 |
| 90 | Pelvic girdle muscle weakness (HP:0003749) | 2.47503237 |
| 91 | CNS hypomyelination (HP:0003429) | 2.47231100 |
| 92 | Premature ovarian failure (HP:0008209) | 2.45196914 |
| 93 | Areflexia of lower limbs (HP:0002522) | 2.44702590 |
| 94 | Joint swelling (HP:0001386) | 2.44168447 |
| 95 | Prominent nose (HP:0000448) | 2.41351443 |
| 96 | Abnormality of eosinophils (HP:0001879) | 2.39150922 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.38360022 |
| 98 | Hypochromic anemia (HP:0001931) | 2.37752144 |
| 99 | Osteomyelitis (HP:0002754) | 2.35144043 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34182380 |
| 101 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.34164311 |
| 102 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.33030948 |
| 103 | Loss of speech (HP:0002371) | 2.32286664 |
| 104 | Muscle fiber splitting (HP:0003555) | 2.31726296 |
| 105 | Glucose intolerance (HP:0000833) | 2.30620915 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 2.30475144 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.29515374 |
| 108 | Spastic tetraparesis (HP:0001285) | 2.28577260 |
| 109 | Abnormality of macrophages (HP:0004311) | 2.26868092 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26796433 |
| 111 | Chronic diarrhea (HP:0002028) | 2.25765901 |
| 112 | Abnormality of the endocardium (HP:0004306) | 2.24990941 |
| 113 | Cellulitis (HP:0100658) | 2.24633267 |
| 114 | Muscle fibrillation (HP:0010546) | 2.23924396 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.23898448 |
| 116 | Male infertility (HP:0003251) | 2.22951184 |
| 117 | Cheilitis (HP:0100825) | 2.22455359 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 2.21144923 |
| 119 | Dysostosis multiplex (HP:0000943) | 2.20640134 |
| 120 | Death in infancy (HP:0001522) | 2.19002583 |
| 121 | Shoulder girdle muscle weakness (HP:0003547) | 2.17891014 |
| 122 | IgG deficiency (HP:0004315) | 2.17029001 |
| 123 | Chronic otitis media (HP:0000389) | 2.16595853 |
| 124 | Tongue fasciculations (HP:0001308) | 2.15252726 |
| 125 | Amyloidosis (HP:0011034) | 2.14109821 |
| 126 | Recurrent bacterial skin infections (HP:0005406) | 2.13706968 |
| 127 | Lymphopenia (HP:0001888) | 2.13213627 |
| 128 | Eczematoid dermatitis (HP:0000976) | 2.13051905 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 2.11130736 |
| 130 | Short nail (HP:0001799) | 2.10940614 |
| 131 | Gingival bleeding (HP:0000225) | 2.10625190 |
| 132 | Pulmonary embolism (HP:0002204) | 2.10337557 |
| 133 | Skin rash (HP:0000988) | 2.09625919 |
| 134 | IgA deficiency (HP:0002720) | 2.08607414 |
| 135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08505663 |
| 136 | Abnormality of glycine metabolism (HP:0010895) | 2.08505663 |
| 137 | Agammaglobulinemia (HP:0004432) | 2.08175465 |
| 138 | Abnormality of the pleura (HP:0002103) | 2.08001788 |
| 139 | Disinhibition (HP:0000734) | 2.07776575 |
| 140 | Recurrent fungal infections (HP:0002841) | 2.06754323 |
| 141 | Arthralgia (HP:0002829) | 2.06557077 |
| 142 | Amaurosis fugax (HP:0100576) | 2.05479708 |
| 143 | Glomerulonephritis (HP:0000099) | 2.04097719 |
| 144 | Recurrent abscess formation (HP:0002722) | 2.03451253 |
| 145 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.03216276 |
| 146 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.03216276 |
| 147 | Acne (HP:0001061) | 2.02602518 |
| 148 | Hematochezia (HP:0002573) | 2.02461675 |
| 149 | Polycythemia (HP:0001901) | 2.02398555 |
| 150 | Heart block (HP:0012722) | 2.01680867 |
| 151 | Secondary amenorrhea (HP:0000869) | 2.01633248 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 2.01121394 |
| 153 | Sparse lateral eyebrow (HP:0005338) | 2.00498379 |
| 154 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98984851 |
| 155 | Nasal polyposis (HP:0100582) | 1.98263301 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.97319062 |
| 157 | Upper motor neuron abnormality (HP:0002127) | 1.96916704 |
| 158 | Trismus (HP:0000211) | 1.96391665 |
| 159 | Restlessness (HP:0000711) | 1.94688402 |
| 160 | Peritonitis (HP:0002586) | 1.94256871 |
| 161 | Emphysema (HP:0002097) | 1.94166998 |
| 162 | Interstitial pulmonary disease (HP:0006530) | 1.93661492 |
| 163 | Keratitis (HP:0000491) | 1.90692697 |
| 164 | Abnormal spermatogenesis (HP:0008669) | 1.90613268 |
| 165 | Premature loss of primary teeth (HP:0006323) | 1.90315384 |
| 166 | Cleft eyelid (HP:0000625) | 1.90291530 |
| 167 | Absent radius (HP:0003974) | 1.89222005 |
| 168 | Ependymoma (HP:0002888) | 1.88035746 |
| 169 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87969365 |
| 170 | Episodic fever (HP:0001954) | 1.87240114 |
| 171 | Abnormal atrioventricular conduction (HP:0005150) | 1.87187354 |
| 172 | Ankle contracture (HP:0006466) | 1.86596686 |
| 173 | Hand muscle atrophy (HP:0009130) | 1.84569975 |
| 174 | Premature rupture of membranes (HP:0001788) | 1.82728936 |
| 175 | Delusions (HP:0000746) | 1.82157080 |
| 176 | Patent foramen ovale (HP:0001655) | 1.82095996 |
| 177 | Prolonged neonatal jaundice (HP:0006579) | 1.81894931 |
| 178 | Recurrent bronchitis (HP:0002837) | 1.81723932 |
| 179 | Posterior subcapsular cataract (HP:0007787) | 1.78198950 |
| 180 | Stillbirth (HP:0003826) | 1.71287103 |
| 181 | Selective tooth agenesis (HP:0001592) | 1.70257197 |
| 182 | Absent hand (HP:0004050) | 1.68439392 |
| 183 | Absent forearm bone (HP:0003953) | 1.68314617 |
| 184 | Aplasia involving forearm bones (HP:0009822) | 1.68314617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.47366819 |
| 2 | TSSK6 | 4.01134927 |
| 3 | WEE1 | 3.98334417 |
| 4 | IRAK4 | 3.32240545 |
| 5 | NEK2 | 3.15968498 |
| 6 | AKT3 | 2.71295974 |
| 7 | EPHA2 | 2.64727030 |
| 8 | ERN1 | 2.61242042 |
| 9 | EIF2AK1 | 2.59562779 |
| 10 | PLK4 | 2.57507065 |
| 11 | NEK1 | 2.42511504 |
| 12 | PRPF4B | 2.41819913 |
| 13 | BRSK2 | 2.35089045 |
| 14 | CSK | 2.16520480 |
| 15 | MAP3K9 | 2.13254163 |
| 16 | GRK7 | 2.09590155 |
| 17 | LATS2 | 1.99377932 |
| 18 | ARAF | 1.98314373 |
| 19 | ALK | 1.97261175 |
| 20 | TXK | 1.96804817 |
| 21 | PLK3 | 1.81931568 |
| 22 | SIK3 | 1.80767763 |
| 23 | PDK3 | 1.80221309 |
| 24 | PDK4 | 1.80221309 |
| 25 | BRSK1 | 1.78966765 |
| 26 | PLK1 | 1.72807371 |
| 27 | EPHB1 | 1.62810986 |
| 28 | TESK2 | 1.62566039 |
| 29 | PDK2 | 1.54971583 |
| 30 | ACVR1B | 1.53640072 |
| 31 | IRAK3 | 1.53514835 |
| 32 | BMPR2 | 1.52039209 |
| 33 | TYK2 | 1.51475590 |
| 34 | TTK | 1.50198722 |
| 35 | BTK | 1.49759204 |
| 36 | MATK | 1.44545825 |
| 37 | MAP4K1 | 1.43972320 |
| 38 | KIT | 1.42824137 |
| 39 | TAOK3 | 1.40137684 |
| 40 | SYK | 1.37875421 |
| 41 | RIPK4 | 1.33821594 |
| 42 | TRIB3 | 1.33271265 |
| 43 | RIPK1 | 1.33153979 |
| 44 | FGR | 1.32899016 |
| 45 | STK3 | 1.32046843 |
| 46 | STK10 | 1.30498728 |
| 47 | TGFBR2 | 1.29836143 |
| 48 | FGFR3 | 1.28034307 |
| 49 | PIM2 | 1.26002305 |
| 50 | NME2 | 1.24977788 |
| 51 | LYN | 1.22788353 |
| 52 | MAP2K3 | 1.20677381 |
| 53 | RPS6KA4 | 1.19370398 |
| 54 | JAK3 | 1.19323948 |
| 55 | HCK | 1.18989941 |
| 56 | IRAK1 | 1.18776856 |
| 57 | CDC42BPA | 1.13204596 |
| 58 | DYRK3 | 1.11048028 |
| 59 | MAP3K3 | 1.10563532 |
| 60 | FGFR4 | 1.09525391 |
| 61 | EEF2K | 1.09292286 |
| 62 | LCK | 1.08088781 |
| 63 | CDK12 | 1.06105598 |
| 64 | CCNB1 | 1.00926346 |
| 65 | PIM1 | 0.99572276 |
| 66 | TAOK2 | 0.99430999 |
| 67 | CHEK2 | 0.96542152 |
| 68 | IKBKB | 0.95503137 |
| 69 | EIF2AK3 | 0.94268163 |
| 70 | MAP3K8 | 0.94238335 |
| 71 | FES | 0.92815079 |
| 72 | MARK3 | 0.92612631 |
| 73 | SRPK1 | 0.91809978 |
| 74 | CSF1R | 0.90110796 |
| 75 | ZAP70 | 0.89519218 |
| 76 | PNCK | 0.88699040 |
| 77 | CDK4 | 0.88144862 |
| 78 | TEC | 0.86899849 |
| 79 | HIPK2 | 0.86714464 |
| 80 | MOS | 0.85989846 |
| 81 | MAP3K1 | 0.85930968 |
| 82 | AURKB | 0.85851735 |
| 83 | TNK2 | 0.85463728 |
| 84 | CHEK1 | 0.85226799 |
| 85 | TBK1 | 0.85100091 |
| 86 | ZAK | 0.82929276 |
| 87 | STK38 | 0.82816413 |
| 88 | JAK1 | 0.80915602 |
| 89 | EPHA3 | 0.77982977 |
| 90 | ITK | 0.77429755 |
| 91 | PAK1 | 0.76103425 |
| 92 | SCYL2 | 0.75607014 |
| 93 | BRAF | 0.74101235 |
| 94 | CLK1 | 0.72139673 |
| 95 | MAP3K13 | 0.67824918 |
| 96 | IRAK2 | 0.64722443 |
| 97 | CDK2 | 0.64625610 |
| 98 | DDR2 | 0.64370369 |
| 99 | KSR2 | 0.64143284 |
| 100 | PRKCI | 0.63691303 |
| 101 | MST1R | 0.62333125 |
| 102 | CDC7 | 0.62068123 |
| 103 | LRRK2 | 0.61700473 |
| 104 | ADRBK2 | 0.61333314 |
| 105 | MAPK11 | 0.61170315 |
| 106 | MTOR | 0.60993982 |
| 107 | MAP3K14 | 0.60273129 |
| 108 | NLK | 0.60032761 |
| 109 | STK38L | 0.59793754 |
| 110 | TAOK1 | 0.58719860 |
| 111 | AURKA | 0.58680746 |
| 112 | PTK6 | 0.58641355 |
| 113 | CHUK | 0.56400023 |
| 114 | PAK4 | 0.53771146 |
| 115 | PIK3CA | 0.53149542 |
| 116 | RAF1 | 0.52880285 |
| 117 | YES1 | 0.51497030 |
| 118 | BMX | 0.51259072 |
| 119 | ATR | 0.50002717 |
| 120 | MAPKAPK2 | 0.48754572 |
| 121 | RPS6KB2 | 0.48516551 |
| 122 | STK24 | 0.47577173 |
| 123 | MAP3K11 | 0.46862449 |
| 124 | PRKCQ | 0.46576194 |
| 125 | PRKAA1 | 0.45976585 |
| 126 | MAP3K2 | 0.45763237 |
| 127 | CAMKK2 | 0.44510178 |
| 128 | MARK2 | 0.43340716 |
| 129 | KSR1 | 0.42795613 |
| 130 | MAP3K5 | 0.41526216 |
| 131 | BLK | 0.40930850 |
| 132 | PRKAA2 | 0.40172754 |
| 133 | CDK7 | 0.38936350 |
| 134 | MAP2K6 | 0.38279087 |
| 135 | CSNK1E | 0.37534417 |
| 136 | PKN2 | 0.37132090 |
| 137 | PRKCD | 0.36691273 |
| 138 | PRKD2 | 0.36112146 |
| 139 | FYN | 0.35505871 |
| 140 | JAK2 | 0.35047775 |
| 141 | EIF2AK2 | 0.34725782 |
| 142 | IKBKE | 0.34218054 |
| 143 | STK4 | 0.32854764 |
| 144 | PDK1 | 0.32558070 |
| 145 | CDK1 | 0.32058910 |
| 146 | CDK6 | 0.30589185 |
| 147 | SMG1 | 0.30525422 |
| 148 | CAMKK1 | 0.30061647 |
| 149 | ABL2 | 0.29641021 |
| 150 | DYRK1B | 0.28986003 |
| 151 | TLK1 | 0.28341779 |
| 152 | PDPK1 | 0.28125727 |
| 153 | PINK1 | 0.27610705 |
| 154 | NEK9 | 0.27218394 |
| 155 | ABL1 | 0.25807037 |
| 156 | GRK6 | 0.25009688 |
| 157 | MAPK3 | 0.24617607 |
| 158 | CSNK2A2 | 0.24374418 |
| 159 | INSR | 0.24356403 |
| 160 | MAPK10 | 0.24224069 |
| 161 | MELK | 0.22512774 |
| 162 | MAPKAPK3 | 0.21744439 |
| 163 | PAK6 | 0.21265196 |
| 164 | ATM | 0.21111461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.08529528 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.98422726 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.46692496 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.03709623 |
| 5 | RNA transport_Homo sapiens_hsa03013 | 2.96478601 |
| 6 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.78276830 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.76004785 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55074745 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.41857261 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38293047 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.23764845 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.02789134 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94566839 |
| 14 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.91850582 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78210103 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74146207 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.73568572 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.73323520 |
| 19 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.70888230 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.57589926 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.51054977 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50189692 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49251047 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47617550 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.46169275 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.46152785 |
| 27 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.45598815 |
| 28 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.44684368 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41010229 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.39488431 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.36556166 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.34006647 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31805712 |
| 34 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.31718307 |
| 35 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.30566712 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27359510 |
| 37 | DNA replication_Homo sapiens_hsa03030 | 1.20638436 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10775593 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10094876 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.09201964 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06191478 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06063863 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05081037 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.03371690 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.00192273 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 0.99216723 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98107104 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.97107404 |
| 49 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.96827154 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.96129062 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.91757168 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90332671 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 0.88748182 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86621432 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86584728 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82061107 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81653564 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80639624 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79011301 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78672469 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.77124653 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76703815 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75876121 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.74034639 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73691286 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73453522 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73116669 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71087558 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70361157 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.69901207 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69647534 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69004117 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67900464 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67571253 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66844267 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63972208 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62547693 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.62379133 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61994990 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61738263 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60666170 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59573809 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.59528185 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59491701 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.59276560 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58542454 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.58184769 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57913017 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57889929 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56074826 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56059676 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55812968 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55431698 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55210217 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55099714 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54291606 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53800340 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53084129 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52741481 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52452282 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52395448 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52185357 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51306916 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50935597 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50213203 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49486561 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49037326 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48550920 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48135675 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47810146 |
| 111 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47159442 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46813992 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.46637931 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46261406 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.45599318 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45519821 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.45496531 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42735698 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41380018 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41315290 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39374810 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38423762 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.38270097 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35899709 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35460505 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35267394 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33720653 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33175693 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32990293 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.32606624 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.32085631 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31985868 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30707598 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27724118 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26925978 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24560486 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22623420 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.22369170 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.21958329 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20708097 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20163278 |
| 142 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19808229 |
| 143 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16695602 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15485900 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15134843 |

